{"entity":{"type":"insider","cik":"0001562371","url":"/insider/0001562371","json_url":"/insider/0001562371.json","name":"Barry Richard","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":18,"first":"2012-12-14","last":"2025-11-24","span_basis":"filed_date"},"name_variants":[{"name":"Barry Richard","source":"filing","n_filings":18,"first_seen":"2012-12-14","last_seen":"2025-11-24"}],"transactions":[{"id":5137453,"accession":"0001437749-25-036125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-036125","line_url":"/filing/0001437749-25-036125#line-1","is_derivative":false,"issuer_cik":"0001069530","issuer_name":"CASSAVA SCIENCES INC","issuer_ticker":"SAVA","issuer_name_source":null,"issuer_url":"/issuer/0001069530","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":2.76,"price_display":"2.76","price_state":"stated","total_value":414000.0,"total_display":"414,000.00","total_whole":"414,000","shares_owned_after":938060.0,"shares_owned_after_display":"938,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-20","filed_date":"2025-11-24","scope":"insider"},{"id":4079688,"accession":"0001437749-25-035882","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-035882","line_url":"/filing/0001437749-25-035882#line-1","is_derivative":false,"issuer_cik":"0001069530","issuer_name":"CASSAVA SCIENCES INC","issuer_ticker":"SAVA","issuer_name_source":null,"issuer_url":"/issuer/0001069530","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":73385.0,"shares_display":"73,385","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":201808.75,"total_display":"201,808.75","total_whole":"201,809","shares_owned_after":788060.0,"shares_owned_after_display":"788,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-19","filed_date":"2025-11-20","scope":"insider"},{"id":4689581,"accession":"0001437749-25-029725","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-029725","line_url":"/filing/0001437749-25-029725#line-1","is_derivative":false,"issuer_cik":"0001069530","issuer_name":"CASSAVA SCIENCES INC","issuer_ticker":"SAVA","issuer_name_source":null,"issuer_url":"/issuer/0001069530","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7172.0,"shares_display":"7,172","price_per_share":2.28,"price_display":"2.28","price_state":"stated","total_value":16352.16,"total_display":"16,352.16","total_whole":"16,352","shares_owned_after":714675.0,"shares_owned_after_display":"714,675","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-22","filed_date":"2025-09-23","scope":"insider"},{"id":5011398,"accession":"0001437749-25-029586","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001437749-25-029586","line_url":"/filing/0001437749-25-029586","is_derivative":false,"issuer_cik":"0001069530","issuer_name":"CASSAVA SCIENCES INC","issuer_ticker":"SAVA","issuer_name_source":null,"issuer_url":"/issuer/0001069530","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":47308.0,"shares_display":"47,308","price_per_share":2.289661790817621,"price_display":"2.29","price_state":"stated","total_value":108319.32,"total_display":"108,319.32","total_whole":"108,319","shares_owned_after":707503.0,"shares_owned_after_display":"707,503","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-19","filed_date":"2025-09-22","scope":"insider","n_lines":2},{"id":5011384,"accession":"0001437749-25-029586","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-25-029586","line_url":"/filing/0001437749-25-029586","is_derivative":false,"issuer_cik":"0001069530","issuer_name":"CASSAVA SCIENCES INC","issuer_ticker":"SAVA","issuer_name_source":null,"issuer_url":"/issuer/0001069530","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":190633.0,"shares_display":"190,633","price_per_share":2.2368840651933297,"price_display":"2.24","price_state":"stated","total_value":426423.92,"total_display":"426,423.92","total_whole":"426,424","shares_owned_after":660195.0,"shares_owned_after_display":"660,195","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-18","filed_date":"2025-09-22","scope":"insider","n_lines":2},{"id":8222986,"accession":"0001209191-23-054442","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-054442","line_url":"/filing/0001209191-23-054442","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":78.81,"price_display":"78.81","price_state":"stated","total_value":3940500.0,"total_display":"3,940,500.00","total_whole":"3,940,500","shares_owned_after":140000.0,"shares_owned_after_display":"140,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-03","filed_date":"2023-11-06","scope":"insider","n_lines":2},{"id":8284610,"accession":"0001069530-23-000043","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001069530-23-000043","line_url":"/filing/0001069530-23-000043#line-2","is_derivative":false,"issuer_cik":"0001069530","issuer_name":"CASSAVA SCIENCES INC","issuer_ticker":"SAVA","issuer_name_source":null,"issuer_url":"/issuer/0001069530","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16571.0,"shares_display":"16,571","price_per_share":16.65,"price_display":"16.65","price_state":"stated","total_value":275907.15,"total_display":"275,907.15","total_whole":"275,907","shares_owned_after":293477.0,"shares_owned_after_display":"293,477","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-22","filed_date":"2023-08-23","scope":"insider"},{"id":8284602,"accession":"0001069530-23-000043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001069530-23-000043","line_url":"/filing/0001069530-23-000043#line-1","is_derivative":false,"issuer_cik":"0001069530","issuer_name":"CASSAVA SCIENCES INC","issuer_ticker":"SAVA","issuer_name_source":null,"issuer_url":"/issuer/0001069530","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1906.0,"shares_display":"1,906","price_per_share":16.8,"price_display":"16.80","price_state":"stated","total_value":32020.8,"total_display":"32,020.80","total_whole":"32,021","shares_owned_after":276906.0,"shares_owned_after_display":"276,906","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-21","filed_date":"2023-08-23","scope":"insider"},{"id":8219349,"accession":"0001069530-23-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001069530-23-000011","line_url":"/filing/0001069530-23-000011#line-2","is_derivative":false,"issuer_cik":"0001069530","issuer_name":"CASSAVA SCIENCES INC","issuer_ticker":"SAVA","issuer_name_source":null,"issuer_url":"/issuer/0001069530","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":77276.0,"shares_display":"77,276","price_per_share":25.76,"price_display":"25.76","price_state":"stated","total_value":1990629.76,"total_display":"1,990,629.76","total_whole":"1,990,630","shares_owned_after":275000.0,"shares_owned_after_display":"275,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-07","filed_date":"2023-03-08","scope":"insider"},{"id":8219345,"accession":"0001069530-23-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001069530-23-000011","line_url":"/filing/0001069530-23-000011#line-1","is_derivative":false,"issuer_cik":"0001069530","issuer_name":"CASSAVA SCIENCES INC","issuer_ticker":"SAVA","issuer_name_source":null,"issuer_url":"/issuer/0001069530","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11565.0,"shares_display":"11,565","price_per_share":26.13,"price_display":"26.13","price_state":"stated","total_value":302193.45,"total_display":"302,193.45","total_whole":"302,193","shares_owned_after":197724.0,"shares_owned_after_display":"197,724","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider"},{"id":6365836,"accession":"0001069530-22-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001069530-22-000041","line_url":"/filing/0001069530-22-000041#line-1","is_derivative":false,"issuer_cik":"0001069530","issuer_name":"CASSAVA SCIENCES INC","issuer_ticker":"SAVA","issuer_name_source":null,"issuer_url":"/issuer/0001069530","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":36159.0,"shares_display":"36,159","price_per_share":23.79,"price_display":"23.79","price_state":"stated","total_value":860222.61,"total_display":"860,222.61","total_whole":"860,223","shares_owned_after":186159.0,"shares_owned_after_display":"186,159","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-23","filed_date":"2022-08-25","scope":"insider"},{"id":2784102,"accession":"0001209191-20-045774","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-045774","line_url":"/filing/0001209191-20-045774","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":158.49908,"price_display":"158.50","price_state":"stated","total_value":4754972.4,"total_display":"4,754,972.40","total_whole":"4,754,972","shares_owned_after":3132280.0,"shares_owned_after_display":"3,132,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-07","filed_date":"2020-08-07","scope":"insider","n_lines":2},{"id":2469494,"accession":"0001209191-20-029918","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-029918","line_url":"/filing/0001209191-20-029918","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":141.264863,"price_display":"141.26","price_state":"stated","total_value":4237945.89,"total_display":"4,237,945.89","total_whole":"4,237,946","shares_owned_after":3163813.0,"shares_owned_after_display":"3,163,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-15","filed_date":"2020-05-15","scope":"insider","n_lines":2},{"id":7884618,"accession":"0001209191-19-049553","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-049553","line_url":"/filing/0001209191-19-049553#line-2","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3309.0,"shares_display":"3,309","price_per_share":87.49,"price_display":"87.49","price_state":"stated","total_value":289504.41,"total_display":"289,504.41","total_whole":"289,504","shares_owned_after":3187065.0,"shares_owned_after_display":"3,187,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-13","filed_date":"2019-09-16","scope":"insider"},{"id":7884613,"accession":"0001209191-19-049553","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-049553","line_url":"/filing/0001209191-19-049553#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1691.0,"shares_display":"1,691","price_per_share":87.4929,"price_display":"87.49","price_state":"stated","total_value":147950.4939,"total_display":"147,950.49","total_whole":"147,950","shares_owned_after":3183756.0,"shares_owned_after_display":"3,183,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-12","filed_date":"2019-09-16","scope":"insider"},{"id":7806337,"accession":"0001209191-19-046851","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-046851","line_url":"/filing/0001209191-19-046851#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":99.3185,"price_display":"99.32","price_state":"stated","total_value":496592.5,"total_display":"496,592.50","total_whole":"496,593","shares_owned_after":3182065.0,"shares_owned_after_display":"3,182,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-20","scope":"insider"},{"id":8619153,"accession":"0001209191-19-045929","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-045929","line_url":"/filing/0001209191-19-045929#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3700.0,"shares_display":"3,700","price_per_share":122.5,"price_display":"122.50","price_state":"stated","total_value":453250.0,"total_display":"453,250.00","total_whole":"453,250","shares_owned_after":3177065.0,"shares_owned_after_display":"3,177,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-14","filed_date":"2019-08-14","scope":"insider"},{"id":8240201,"accession":"0001209191-19-045752","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-045752","line_url":"/filing/0001209191-19-045752#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1300.0,"shares_display":"1,300","price_per_share":122.5,"price_display":"122.50","price_state":"stated","total_value":159250.0,"total_display":"159,250.00","total_whole":"159,250","shares_owned_after":3173365.0,"shares_owned_after_display":"3,173,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-13","scope":"insider"},{"id":6558923,"accession":"0001209191-18-040091","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-040091","line_url":"/filing/0001209191-18-040091#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":130.34,"price_display":"130.34","price_state":"stated","total_value":9775500.0,"total_display":"9,775,500.00","total_whole":"9,775,500","shares_owned_after":3170432.0,"shares_owned_after_display":"3,170,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-27","filed_date":"2018-06-29","scope":"insider"},{"id":3317059,"accession":"0001209191-16-108954","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-108954","line_url":"/filing/0001209191-16-108954#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":15.6558,"price_display":"15.66","price_state":"stated","total_value":1174185.0,"total_display":"1,174,185.00","total_whole":"1,174,185","shares_owned_after":3241014.0,"shares_owned_after_display":"3,241,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-14","filed_date":"2016-03-16","scope":"insider"},{"id":2590565,"accession":"0001562371-12-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562371-12-000004","line_url":"/filing/0001562371-12-000004#line-1","is_derivative":false,"issuer_cik":"0001109196","issuer_name":"TELIK INC","issuer_ticker":"TELK","issuer_name_source":null,"issuer_url":"/issuer/0001109196","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48390.0,"shares_display":"48,390","price_per_share":1.8609,"price_display":"1.86","price_state":"stated","total_value":90048.951,"total_display":"90,048.95","total_whole":"90,049","shares_owned_after":243800.0,"shares_owned_after_display":"243,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-17","filed_date":"2012-12-19","scope":"insider"},{"id":2229636,"accession":"0001562371-12-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562371-12-000003","line_url":"/filing/0001562371-12-000003#line-2","is_derivative":false,"issuer_cik":"0001109196","issuer_name":"TELIK INC","issuer_ticker":"TELK","issuer_name_source":null,"issuer_url":"/issuer/0001109196","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40920.0,"shares_display":"40,920","price_per_share":2.3134,"price_display":"2.31","price_state":"stated","total_value":94664.328,"total_display":"94,664.33","total_whole":"94,664","shares_owned_after":292200.0,"shares_owned_after_display":"292,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-13","filed_date":"2012-12-14","scope":"insider"},{"id":2229634,"accession":"0001562371-12-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562371-12-000003","line_url":"/filing/0001562371-12-000003#line-1","is_derivative":false,"issuer_cik":"0001109196","issuer_name":"TELIK INC","issuer_ticker":"TELK","issuer_name_source":null,"issuer_url":"/issuer/0001109196","owner_cik":"0001562371","owner_name":"Barry Richard","owner_display_name":"Barry Richard","owner_url":"/insider/0001562371","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61798.0,"shares_display":"61,798","price_per_share":1.8739,"price_display":"1.87","price_state":"stated","total_value":115803.2722,"total_display":"115,803.27","total_whole":"115,803","shares_owned_after":292200.0,"shares_owned_after_display":"292,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-12","filed_date":"2012-12-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":20,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001069530","name":"CASSAVA SCIENCES INC","url":"/issuer/0001069530","role":"Director, Officer (President & CEO)","n_filings":7,"first_seen":"2022-08-25","last_seen":"2025-11-24"},{"type":"issuer","type_label":"ISSUER","cik":"0000873303","name":"Sarepta Therapeutics, Inc.","url":"/issuer/0000873303","role":"Director","n_filings":9,"first_seen":"2016-03-16","last_seen":"2023-11-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001109196","name":"TELIK INC","url":"/issuer/0001109196","role":"Ten percent owner","n_filings":2,"first_seen":"2012-12-14","last_seen":"2012-12-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001562371","retrieved_at":"2026-08-23T12:29:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}